AAMD 2024
Beyond Fractionation: A Review of Clinical Criteria Required for SRS and SBRT Techniques
The stereotactic technique has quickly become a standard of care for many cancer centers; however, it is not unusual to find this commonly utilized treatment modality difficult to authorize even when dosing and fractionation expectations have been met. This session will focus on additional published clinical coverage criteria required to be met in order to receive authorization or reimbursement. Being knowledgeable of these criteria and confirming the information is documented prior to authorization may lessen delays in treatment and additional time and effort by you and your peers. Tips and tricks for quality documentation to support these criteria will be discussed, as well as appropriate coding and documentation for courses when the published stereotactic criteria are not met.
Learner Outcomes:
- Recognize the key dose and fractionation criteria required for the SRS and SBRT techniques
- Discuss the clinical coverage criteria published for the stereotactic techniques per treatment area or diagnosis
- Identify best practice options for documentation of the clinical coverage criteria
CE credit = 1.0
Tamara Syverson, BSRT(T), CHONC
Executive Director, Oncology Client Services
Revenue Cycle Coding Strategies
Tamara Syverson, BSRT(T), CHONC is the Executive Director, Oncology Client Services of Revenue Cycle Coding Strategies, LLC. She is a frequent speaker and author for nationally recognized professional organizations and publications. Tamara’s areas of expertise include oncology coding and compliance, physician and hospital outpatient reimbursement, electronic medical record systems, and oncology operations improvement. Tamara often speaks at national conferences on many topics including radiation and medical oncology coding, compliance, reimbursement, and operational workflow.
Tamara also works with cancer centers, hospitals and physician practices across the US, as well as commercial payers and benefit management companies to provide assessments, education and implementation of operational improvements. Tamara also serves as a specialty auditor and expert witness in the field of radiation oncology for the Office of Inspector General (OIG).
Tamara has worked in the radiation oncology specialty for over 25 years and holds a Bachelor of Science in Radiation Therapy from the University of Oklahoma Health Sciences Center.
Sponsors
